Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romosozumab Followed by Denosumab vs Zoledronic Acid in Postmenopausal Osteoporosis
NCT07772609Phase 4Not yet recruiting
- Sponsor
- Sahlgrenska University Hospital
- Start
- Jan 2027
- Primary completion
- Dec 2029
- Countries
- 1
01
Overview
A Phase 4 trial of romosozumab in osteoporosis, sponsored by Sahlgrenska University Hospital. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
romosozumab
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT07772609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07772609.